Status:
COMPLETED
Effects of Pectin Supplementation in Diarrhea-predominant Irritable Bowel Syndrome
Lead Sponsor:
Nanjing PLA General Hospital
Conditions:
Irritable Bowel Syndrome
Eligibility:
All Genders
18-70 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to investigate the effect of pectin, a kind of soluble dietary fiber, on clinical symptoms, gut microbiota and the immune status in patients with diarrhea-predominant irri...
Detailed Description
Patients were randomized to receive either pectin or placebo. Treatment consisted of 6 weeks supplementation with pectin (fiber group) or placebo (maltodextrin). We evaluated the clinical symptoms, gu...
Eligibility Criteria
Inclusion
- All patients(age≧18y)
- Admitted for diarrhea-predominant irritable bowel syndrome
Exclusion
- Mental disorders
- Cancer
- Inflammatory bowel disease
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2013
Estimated Enrollment :
114 Patients enrolled
Trial Details
Trial ID
NCT02270268
Start Date
November 1 2011
End Date
October 1 2013
Last Update
March 24 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.